ZINLIRVIMAB

UNII:	L98LJF15I9
Formula:
Preferred Substance Name:	ZINLIRVIMAB
GSRS Full Record:	L98LJF15I9 i

2417213-75-1
10-1074
ANTI-HIV-1 HUMAN MONOCLONAL ANTIBODY TARGETING V3 GLYCAN SUPERSITE ON THE HIV-1 ENVELOPE PROTEIN (10-1074)
IMMUNOGLOBULIN G1 (443-LEUCINE,449-SERINE), ANTI-(HUMAN IMMUNODEFICIENCY VIRUS 1 ENVELOPE PROTEIN GP120ENV) (HUMAN MONOCLONAL 2G2-55D10 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 2G2-55D10 .LAMBDA.-CHAIN, DIMER
ZINLIRVIMAB [INN]
ZINLIRVIMAB [USAN]
ZINLIRVIMAB [WHO-DD]

Common Chemistry
i
Inxight Drugs
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

ZINLIRVIMAB

Synonyms and Mappings

Resources